TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE
POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE
Approval overview TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE is listed in Drugs@FDA under application 211572 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE Form and strength SOLUTION/DROPS;OPHTHALMIC - 10,000 UNITS/ML;EQ 1MG BASE/ML Sponsor SOMERSET THERAPS LLC Submission history Latest submission status date: 2024-08-05 00:00:00.
Structured Monograph
Clinical summary
Approval overview TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE is listed in Drugs@FDA under application 211572 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE Form and strength SOLUTION/DROPS;OPHTHALMIC - 10,000 UNITS/ML;EQ 1MG BASE/ML Sponsor SOMERSET THERAPS LLC Submission history Latest submission status date: 2024-08-05 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.